Targeting inflammation to reduce cardiovascular disease risk

Pasquale Maffia; Giuseppe Cirino

doi:10.1111/bph.14039

Targeting inflammation to reduce cardiovascular disease risk

Br J Pharmacol. 2017 Nov;174(22):3895-3897. doi: 10.1111/bph.14039.

Authors

Pasquale Maffia^{1

2

3}, Giuseppe Cirino³

Affiliations

¹ Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
² Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
³ Department of Pharmacy, University of Naples Federico II, Naples, Italy.

Abstract

This joint themed section of the British Journal of Pharmacology and the British Journal of Clinical Pharmacology stems from a joint British Pharmacological Society - Italian Society of Pharmacology symposium held at the 37^th National Congress of the Italian Society of Pharmacology in Naples (Italy) from 27 to 30 October 2015.

Linked articles: This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Anti-Inflammatory Agents / therapeutic use*
Cardiovascular Diseases / immunology
Cardiovascular Diseases / prevention & control*
Humans
Inflammation / drug therapy
Inflammation / immunology
Risk

Substances

Anti-Inflammatory Agents

Abstract

Publication types

MeSH terms

Substances

Grants and funding